Non-Transfusion-dependent Alpha-Thalassemia
2 clinical trials · Condition
◉ Watch Non-Transfusion-dependent Alpha-Thalassemia
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) (NCT04770753) | Agios Pharmaceuticals, Inc. | 2021-12-20 |
Track Non-Transfusion-dependent Alpha-Thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.